Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr₹1,091 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹419 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr
Mar2020₹1,091 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr
11.66
Mar2020 ₹1,091 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,050.0 Cr 1.6% -7.3% 39.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹122,835.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 2% -2.4% -13.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

-7.3%

39.2%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses